Nino Keshelava
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Neuroblastoma Research and Treatments, Lung Cancer Treatments and Mutations, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research
Most-Cited Works
- Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.(2001)
- Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.(1998)
- → E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase(2007)184 cited
- → Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells(2008)178 cited
- → Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program(2007)120 cited
- → Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide(2007)106 cited
- → National Cancer Institute pediatric preclinical testing program: Model description for in vitro cytotoxicity testing(2010)99 cited
- → Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program(2009)63 cited
- → DIMSCAN: A Microcomputer Fluorescence-Based Cytotoxicity Assay for Preclinical Testing of Combination Chemotherapy(2005)63 cited
- → Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines(2013)61 cited